login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Arthritis Drug Vioxx Doubles Heart Attack Risk: Drug Claims Pour In
Federal Court judge Christopher Jessop awarded 287,000 dollars (259,000 US) to Graeme Peterson, who sued the company after a 2003 heart attack left him unable to work.
"I have concluded that across a population the consumption of Vioxx about doubled the risk of heart attack," the judge said.
"I have held that because Vioxx involved about a doubling of the risk of heart attack, it was not reasonably fit for the purpose of being used for the relief of arthritic pain."
Merck said it disagreed with the judgement and would appeal. Law firm Slater and Gordon said it knows of 500 Australians who could make similar claims and there may be hundreds more.
"This is truly one for the true believers," said Slater and Gordon deputy chairman Peter Gordon, urging Merck to compensate all affected Australians.
"This is truly a victory for the ages, a victory for justice. The sort of victory you don't see in Australian courts every day."
Merck has paid billions of dollars to litigants after pulling Vioxx from sale in 2004, following an internal study which showed it doubled the risks of heart attack in patients who took it for 18 months or longer.
In November, a published analysis of 30 Vioxx trials said the company could have detected the anti-inflammatory drug's risks nearly four years before its withdrawal.
Source-AFP
TAN
|
|
More News on: Chest Pain, Drug Toxicity, Osteoarthritis, Oligoarthritis, Cardiac Risk or Risk of heart Attack, Physiotherapy Utilities, Cardiac Catheterization, Heart Attack, Spondylolisthesis, Diet Lifestyle and Heart Disease
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
 | Quiz on Heart A quiz on heart to learn more about its functions. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Heart Attack
Complete Medindia Resources
|
| News Categories: |
| » | Revision in Quality Standards for Heparin |
| » | Acne Drug Users At High Risk of Developing Eye Infections |
| » | Patients Who Take Antidepressants When in ICU More Likely to Die |
| » | New Tablet Coating Product by Ideal Cures, In Geneva |
| » | Prednisolone Benefits Patients With Bell's Palsy |
| More Drug News | |
|
Drug Related News |
||||||||
| » | Revision in Quality Standards for Heparin | » | Acne Drug Users At High Risk of Developing Eye Infections | |||||
| » | Patients Who Take Antidepressants When in ICU More Likely to Die | » | New Tablet Coating Product by Ideal Cures, In Geneva | |||||
| » | Prednisolone Benefits Patients With Bell's Palsy | » | 'Orphan' Sleep Drug may Fight Cancer | |||||
| » | New Drugs for Fox Tapeworm Infection | » | Poor Quality Antimalarial Drugs Pose Threat | |||||
| Read More >> | ||||||||
